News

Statement from OCRFA President & CEO Audra Moran on th...

Statement from OCRFA President & CEO Audra Moran on the Death of U.S. Representative Louise Slaughter

March 16, 2018

(March 16, 2018) On behalf of Ovarian Cancer Research Alliance I want to extend our deepest condolences on the passing of U.S. Representative Louise Slaughter. As the author of the landmark Genetic Information Nondiscrimination Act (GINA), signed into law in 2008 after a 14-year battle, Representative Slaughter proved to be a tireless advocate for patients … Continued

OCRA News

Discovery of New Gene Mutation That Increases Ovarian Cance...

Discovery of New Gene Mutation That Increases Ovarian Cancer Risk, Passed Down Through Paternal Lineage

February 22, 2018

(February 22, 2018) Researchers at Roswell Park Comprehensive Cancer Center, including Kunle Odunsi, MD, PhD, senior author of the study and current OCRFA Scientific Advisory Committee member, have discovered a mutation of an unidentified gene that increases both the risk of early onset ovarian cancer and prostate cancer. Using the Familial Ovarian Cancer Registry at … Continued

OCRA News

US Preventive Services Task Force: Ovarian Cancer Screening...

US Preventive Services Task Force: Ovarian Cancer Screening Not Effective for Low-Risk Women

February 14, 2018

(February 14, 2018) Today the US Preventive Task Force updated their recommendation on ovarian cancer screening, reaffirming their 2012 position that screening average risk women for ovarian cancer is not effective in reducing mortality from the disease. Furthermore, they stated that screening for ovarian cancer carries certain risk and harms that may be substantial, and … Continued

Research

World Cancer Day is February 4

World Cancer Day is February 4

February 2, 2018

On World Cancer Day, the world comes together to defeat cancer. Ovarian cancer is a worldwide disease. The cure starts right here. At OCRFA, we’re making progress every day toward a world without ovarian cancer. We’re funding top scientists performing the most innovative research in the field. We’re helping women and their families face challenges … Continued

Community

Ovarian Cancer Risk and BRCA1 Methylation

Ovarian Cancer Risk and BRCA1 Methylation

January 31, 2018

(January 31, 2018) A study published in the Annals of Internal Medicine explains that researchers now believe that the methylation of normal BRCA1 gene promotion, not solely BRCA1 mutation, is a risk factor for ovarian cancer. Methylation can be detrimental because it blocks a gene from being transcribed, which means that it can’t repair any … Continued

Research

Super Saturday: Coming to Manhattan in 2018

Super Saturday: Coming to Manhattan in 2018

January 30, 2018

(January 30, 2018) Ovarian Cancer Research Alliance has hosted Super Saturday in the Hamptons for the past 20 years. Now, we’re delighted to announce that our iconic event will move to Manhattan in September 2018. This new event will have everything you’ve loved (hands-on shopping with top designers) with lots of additions (tastings, mixologists, virtual … Continued

Events

HIPEC Beneficial in Late Stage Ovarian Cancer

HIPEC Beneficial in Late Stage Ovarian Cancer

January 29, 2018

(January 29, 2018) A study recently published in the New England Journal of Medicine looked at the difference between two treatment strategies for newly diagnosed stage III epithelial ovarian cancer patients, with the goal of identifying the treatment with a higher rate of recurrence free survival. The first treatment option, typical for advanced stage ovarian … Continued

Research

Can Cancer Be Detected and Located by a Blood Test?

Can Cancer Be Detected and Located by a Blood Test?

January 25, 2018

(January 25, 2018) CancerSEEK is a blood test designed to detect cancer by analyzing levels of proteins and mutations in cell-free DNA. The goal of this particular blood test is to assist in early detection, and therefore decrease cancer related deaths, for ovarian, liver, stomach, pancreas, esophagus, colorectum, lung, and/or breast cancers. The results of … Continued

Research

OCRFA Awards $5.3 Million in Scientific Research Grants for...

OCRFA Awards $5.3 Million in Scientific Research Grants for 2018

January 25, 2018

(January 25, 2018) OCRFA has just awarded more than $5.3 million in new scientific research grants for ovarian cancer, bringing our total investment in life-saving research to over $80 million. This year’s grants have been awarded to twenty top scientists at sixteen leading medical centers across the country. “Our 2018 grantees are truly some of … Continued

OCRA News

Deadline: Midnight – Donation Match Ending 12/31

Deadline: Midnight – Donation Match Ending 12/31

December 31, 2017

Make your 2017 tax-deductible gift NOW! We work every day to fund cures, foster community, further conversations and ultimately, advance the cause. We do this by supporting women fighting ovarian cancer and the friends and families who love them, by working with scientists to eradicate the disease and policymakers who make it possible, and by … Continued

OCRA News

Today’s Gift Could Be Tomorrow’s Cure

Today’s Gift Could Be Tomorrow’s Cure

December 28, 2017

(December 28, 2017) Progress is being made every day, and scientists are on the threshold of many more important discoveries – but we need your help to continue investing in cutting-edge research that will one day lead to a cure, and to keep fighting on Capitol Hill for policies that help women receive the highest … Continued

OCRA News

OCRFA Research Shows Novel Combination Therapy Effective in...

OCRFA Research Shows Novel Combination Therapy Effective in Ovarian Cancer

December 20, 2017

(December 20, 2017) Cell Reports published new research from the Wistar Institute, which looked at the potential benefits of a therapy that combines PARP inhibitors and BET inhibitors for ovarian cancer patients without BRCA mutations. The research was funded in part by an OCRFA grant to Rugang, Zhang, PhD. PARP inhibitors have already been approved … Continued

OCRA News